1 Similarly, the active ingredient tirzepatide is marketed by Eli Lilly as two separate drugs under the brand names Mounjaro (injection for diabetes, approved in 2022) and Zepbound (injection for weight loss, approved in 2023)
however, it is still premature to advise patients to begin or cease taking these medications should they be concerned about the relationship to AMD
A compound with a genuine 28.7% weight-loss signal is a compound where dosing errors translate into larger, not smaller, consequences
And for postpartum women carrying 20, 30, or 50 extra pounds, the appeal is obvious
Without insurance, the brand name weight loss drugs can cost more than a thousand dollars a month